| Literature DB >> 19479394 |
A Heisel1, M Berg, M Stopp, D Ukena, H Schieffer.
Abstract
Amiodarone is highly effective in suppressing ventricular and supraventricular tachyarrhythmias. The most serious adverse reaction is pulmonary toxicity. The mechanisms involved in amiodarone-induced pulmonary injury are incompletely understood. Several forms of pulmonary disease occur including interstitial pneumonitis, fibrosis or organizing pneumonia. The incidence is generally lower with lower maintenance doses (<or= 300 mg/d). There are no adequate predictors of pulmonary toxicity due to amiodarone. The diagnosis of amiodarone-induced pulmonary toxicity is one of exclusion. Treatment consists primarily of stopping amiodarone application. Corticosteroid therapy can be life-saving for severe cases and for patients in whom withdrawl of amiodarone is not possible.Entities:
Mesh:
Substances:
Year: 1997 PMID: 19479394 DOI: 10.1007/BF03041977
Source DB: PubMed Journal: Med Klin (Munich) ISSN: 0723-5003